CS7 COST-EFFECTIVENESS AND BUDGET IMPACT OF INTRODUCING ROSUVASTATIN INTO THE BRAZILIAN NATIONAL DRUG FORMULARY

Value in Health ◽

10.1016/s1098-3015(10)75300-6 ◽

2009 ◽

Vol 12 (7) ◽

pp. A486-A487

Author(s):

MR Godoy ◽

RLP Bueno

Keyword(s):

Cost Effectiveness ◽

Budget Impact ◽

Drug Formulary ◽

Download Full-text

PCV46 COST-EFFECTIVENESS AND BUDGET IMPACT OF INTRODUCING FLUVASTATIN XL 80 MG INTO THE BRAZILIAN NATIONAL DRUG FORMULARY

Value in Health ◽

10.1016/s1098-3015(10)73808-0 ◽

2009 ◽

Vol 12 (3) ◽

pp. A149

Author(s):

MR Godoy ◽

RLP Bueno ◽

C Suzuki

Keyword(s):

Cost Effectiveness ◽

Budget Impact ◽

Drug Formulary ◽

Download Full-text

PRS2 BUDGET IMPACT ANALYSIS OF INTRODUCTION FLUTICASONE PROPIONATE/SALMETEROL (500/50 MG) INTO THE BRAZILIAN NATIONAL DRUG FORMULARY

Value in Health ◽

10.1016/s1098-3015(10)75494-2 ◽

2009 ◽

Vol 12 (7) ◽

pp. A525

Author(s):

MR Godoy ◽

RLP Bueno

Keyword(s):

Fluticasone Propionate ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Drug Formulary ◽

Download Full-text

The economic impact of introducing HIV/AIDS guideline into Colombian National Drug Formulary. Cost-effectiveness analysis

International Journal of Infectious Diseases ◽

10.1016/j.ijid.2010.02.2027 ◽

2010 ◽

Vol 14 ◽

pp. e242-e243

Author(s):

E.V. Lemos Luengas ◽

B.C. Castañeda ◽

E. Quevedo ◽

C. Castillo ◽

L.R. Lemos

Keyword(s):

Cost Effectiveness ◽

Economic Impact ◽

Cost Effectiveness Analysis ◽

Drug Formulary ◽

Effectiveness Analysis ◽

National Drug ◽

Download Full-text

Cost-utility Analysis, Cost-effectiveness Analysis, Budget Impact Analysis

Case Medical Research ◽

10.31525/ct1-nct04283565 ◽

2020 ◽

Author(s):

Keyword(s):

Cost Effectiveness ◽

Impact Analysis ◽

Budget Impact ◽

Cost Utility ◽

Cost Effectiveness Analysis ◽

Cost Utility Analysis ◽

Budget Impact Analysis ◽

Utility Analysis ◽

Effectiveness Analysis

Download Full-text

PIN150 Economic VALUE of Treatment and Vaccine Technologies to Address the COVID-19 Pandemic: A Cost-Effectiveness and Budget IMPACT Analysis

Value in Health ◽

10.1016/j.jval.2020.08.991 ◽

2020 ◽

Vol 23 ◽

pp. S568

Author(s):

W. Padula ◽

S. Malaviya ◽

N. Reid ◽

F. Chingcuanco ◽

J. Ballreich ◽

...

Keyword(s):

Cost Effectiveness ◽

Impact Analysis ◽

Budget Impact ◽

Economic Value ◽

Budget Impact Analysis

Download Full-text

The National Drug Formulary Listing Process for Orphan Drugs in South Korea: narrative review focused on pricing and reimbursement pathways

Expert Opinion on Orphan Drugs ◽

10.1080/21678707.2021.1913121 ◽

2021 ◽

Author(s):

Joon Seok Bang ◽

Jong Hyuk Lee

Keyword(s):

South Korea ◽

Orphan Drugs ◽

Narrative Review ◽

Drug Formulary ◽

Formulary Listing ◽

National Drug ◽

Pricing And Reimbursement

Download Full-text

PCV8 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison with Dabigatran Under the Brazilian Private Health Care System Perspective

Value in Health ◽

10.1016/j.jval.2011.08.1580 ◽

2011 ◽

Vol 14 (7) ◽

pp. A545

Author(s):

A. Schiola ◽

A.P. Silva ◽

N.B. Santoni ◽

L. Paladini ◽

V. Teich ◽

...

Keyword(s):

Health Care ◽

Cost Effectiveness ◽

Knee Arthroplasty ◽

Impact Analysis ◽

Budget Impact ◽

Thromboembolic Events ◽

Private Health Care ◽

System Perspective ◽

Prevention Of Thromboembolic Events ◽

Hip And Knee Arthroplasty

Download Full-text

Implantable Cardiac Monitor Compared with Conventional Diagnostic for Unexplained Syncope: A Combined Cost-Effectiveness and Budget-Impact Analysis

Value in Health ◽

10.1016/j.jval.2018.04.1116 ◽

2018 ◽

Vol 21 ◽

pp. S166

Author(s):

RC Lucchetta ◽

BS Riveros ◽

MP Rosim ◽

P Holanda ◽

M Melo ◽

...

Keyword(s):

Cost Effectiveness ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Cardiac Monitor ◽

Unexplained Syncope ◽

Implantable Cardiac Monitor

Download Full-text

PCN99 THE COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF RITUXIMAB(HANLIKANG) FOR PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN CHINA

Value in Health ◽

10.1016/j.jval.2019.09.296 ◽

2019 ◽

Vol 22 ◽

pp. S455

Author(s):

M.M. Zhao ◽

Y. Xiang ◽

W. Juying ◽

S.H. Jia ◽

B.B. Chen ◽

...

Keyword(s):

Cost Effectiveness ◽

B Cell ◽

Impact Analysis ◽

Budget Impact ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Budget Impact Analysis ◽

Large B Cell Lymphoma ◽

The Cost ◽

Download Full-text

Cost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspective

ClinicoEconomics and Outcomes Research ◽

10.2147/ceor.s180067 ◽

2018 ◽

Vol Volume 10 ◽

pp. 791-803 ◽

Author(s):

Dhvani Shah ◽

Nancy A Risebrough ◽

Johnna Perdrizet ◽

Neeraj N Iyer ◽

Cory Gamble ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Cost Effectiveness ◽

Managed Care ◽

Budget Impact ◽

Diabetes Patients

Download Full-text